Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement.
Lancet Infect Dis
; 23(4): e122-e137, 2023 04.
Article
in En
| MEDLINE
| ID: mdl-36868253
Full text:
1
Database:
MEDLINE
Main subject:
Tuberculosis
/
Tuberculosis, Multidrug-Resistant
/
Mycobacterium tuberculosis
Type of study:
Diagnostic_studies
/
Guideline
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Lancet Infect Dis
Journal subject:
DOENCAS TRANSMISSIVEIS
Year:
2023
Type:
Article